Atrial fibrillation (AF) is the most common arrhythmia in patients affected by cardiomyopathies. Reports estimate a prevalence of 27% in patients with hypertrophic cardiomyopathy (HCM) and 40% in patients with cardiac amyloidosis (CA). The presence of AF typically results in progressive functional decline, an increased frequency of hospitalizations for heart failure, and a higher thromboembolic risk. Medical management using mainly beta-blockers or amiodarone has produced variable outcomes and a high rate of recurrence. Catheter ablation reduces symptom burden and complications despite a moderate rate of recurrence. Recent evidence suggests that an early rhythm control strategy may lead to more favorable short- and long-term outcomes. In this review, we summarize contemporary data on the management of AF in patients with cardiomyopathy (HCM and CA) with particular reference to the timing and outcomes of ablation procedures.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10816101 | PMC |
| http://dx.doi.org/10.3390/jcm13020501 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Pre-procedural TMAO as a predictor for recurrence of atrial fibrillation after catheter ablation.
BMC Cardiovasc Disord
December 2024
Department of Cardiology, The Affiliated Huaian No. 1 People's Hospital of Nanjing Medical University, Huai'an, 223300, China.
Background: Numerous studies have demonstrated the significance of trimethylamine-N-oxide (TMAO) in the progression of atrial fibrillation (AF). However, the association between TMAO and AF recurrence (RAF) post-catheter ablation is not yet fully understood. This study aims to elucidate the predictive capability of pre-procedural TMAO levels in determining RAF following catheter ablation (CA).
View Article and Find Full Text PDFPharmacotherapy of patients with heart failure and atrial fibrillation: let's get the evidence!
Eur Heart J Cardiovasc Pharmacother
December 2024
Medical Clinic I, Cardiology and Angiology, Justus-Liebig-University, Giessen.
Impact of percutaneous left atrial appendage occlusion on the severity of ischemic stroke.
Cardiovasc Revasc Med
December 2024
Division of Cardiovascular Medicine, University of Toledo Medical Center, Toledo, OH, United States of America. Electronic address:
Background: Percutaneous left atrial appendage occlusion (pLAAO) presents an alternative to anticoagulation (AC) for stroke prophylaxis in atrial fibrillation (Afib) patients with high bleeding risk. pLAAO was associated with lower rates of disabling stroke which was mainly attributed to the reduction of hemorrhagic stroke (HS). Little is known about the impact of pLAAO on the severity of ischemic strokes which we sought to study.
View Article and Find Full Text PDFTiming of oral anticoagulation in acute ischaemic stroke and non-valvular atrial fibrillation: early, 'timely' or late?
Open Heart
December 2024
Liverpool Centre for Cardiovascular Science, at University of Liverpool, Liverpool John Moores University and Liverpool Heart & Chest Hospital, Liverpool, United Kingdom, Liverpool, UK
Frailty may be a new predictive factor of recurrence after radiofrequency catheter ablation in elderly atrial fibrillation patients.
Geriatr Nurs
December 2024
Department of urology, Mianyang Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Changjia Road No.12, Jingzhong District, ZIP Code 621099, Mianyang, Sichuan, China.. Electronic address:
Background: Frailty and atrial fibrillation (AF) outcomes require in-depth, multidimensional investigation. We aim to explore the association between frailty and factors such as hospital stay, quality of life, and recurrence after radiofrequency catheter ablation (RFCA) in elderly patients.
Methods: We conducted a prospective cohort study involving 195 hospitalized elderly AF patients.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!